Ventripoint Diagnostics is a medical device company engaged in the development and commercialization of a breakthrough non-invasive diagnostic tool to monitor patients with heart disease and congenital heart problems for both pediatrics and adults. The VMS+ is the first cost effective and accurate system for measuring the function of all four chambers of the heart and is the only approved way to provide volumetric cardiac assessment with accuracy equivalent to MRI.

Ventripoint Diagnostics logo



Event details

Date: September 14 - 16, 2020

Event contact

Patricia Cosgrove
Area Director
USA: Life Sciences


16 in total